STENOLY PREPARES EU ROLLOUT AS DOCTORS SEEK RELIEF FROM ADMINISTRATIVE BURDEN
An AI-powered medical documentation platform developed in Norway is preparing for a wider European rollout, as healthcare systems across the continent grapple with rising administrative pressure on clinicians.
Stenoly, which launched in its home market in the summer of 2025, has signed up close to 1,000 registered doctors, with more than 150 paying subscribers. The early traction has provided what the company describes as clear evidence of product-market fit in a healthcare environment known for stringent expectations around data protection and clinical reliability.
Stenoly is designed to reduce the time clinicians spend on documentation by automatically capturing and structuring journal-ready notes during patient consultations. The platform operates without local installation, integrates with existing electronic patient journal systems, and has been built with privacy, data security and GDPR compliance as core principles.
The company now plans to expand beyond Norway, with a formal European rollout scheduled to begin in February 2026. Initial target markets include Switzerland, Belgium, Austria and Italy, selected for their comparable regulatory frameworks and demand for digital health productivity tools.
To support this next phase, Stenoly has appointed Espen Fretheim Loeng as Commercial Director. Loeng, who takes up the role on 1 January 2026, will lead the firm’s commercial strategy and oversee international expansion.
“Doctors across Europe are facing the same structural problem: too much time spent on documentation and too little with patients,” says Espen Fretheim Loeng, Commercial Director at Stenoly. “What we have proven in Norway is that clinicians are willing to adopt new tools if they are reliable, easy to use, and compliant. My focus is to replicate that success market by market.”
Rather than pursuing rapid deployment, the company says it will work closely with local healthcare professionals and partners in each country to ensure regulatory alignment and clinical relevance before scaling further.
“Norway is a tough market with high expectations around data protection, quality, and clinical usefulness,” says Loeng. “Reaching nearly 1,000 doctors in a short time gives us confidence that the model scales beyond one healthcare system.”
According to Stenoly, doctors using the platform typically report saving between one and two hours per working day on documentation, time that is redirected either towards patient care or towards reducing working hours.
“Across our Norwegian user base, doctors typically report saving between one and two hours per working day on documentation. That time is largely reallocated to patient care or simply leaving work on time, which has a measurable effect on workload and burnout,” finishes Loeng.
Stenoly is currently used by general practitioners and medical specialists across multiple disciplines. The company operates a subscription-based model with a free trial period and positions its product as a productivity tool rather than a clinical decision-making system. Further market launches and partnerships are expected to be announced throughout 2026 as the European expansion progresses.
